Discovery of Ureido-Based Apcin Analogues as Cdc20-specific Inhibitors against Cancer
Open Access
- 15 February 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (2) , 304
Abstract
Cdc20 is a promising drug target that plays an important role in the mid-anaphase process of cellular mitosis, and Apcin is the only reported core structure of the Cdc20-specific inhibitor. Some potent Apcin derivatives were obtained in our previous research, and a structure–activity relationship was determined. In this study, we designed and synthesized a series of ureido-based Apcin derivatives. The proliferation-inhibition experiments on four cancer-cell lines showed that ureido skeleton could promote the anti-proliferation activity of purine-substituted compounds, whereas the ureido analogues with pyrimidine substitutes showed no significant improvement in the inhibitory effect compared with the original ones. Further tests confirmed that ureido-based compounds can enhance the binding affinity to Cdc20 by increasing the levels of Cdc20 downstream proteins. Compound 27 revealed a remarkably antitumor activity pattern against Hela (IC50 = 0.06 ± 0.02 μM) and potent binding affinity to Cdc20. Moreover, compound 20 induced caspase-dependent apoptosis and cell-cycle arrest at the G2/M phase, and compound 27 induced caspase-dependent apoptosis and promoted microtubule polymerization. Finally, a molecular-docking simulation was performed for compounds 20 and 27 to predict the potential ligand–protein interactions with the active sites of the Cdc20 proteins.Keywords
Funding Information
- National Natural Science Foundation of China (82273789, 82173691, 2022JJ30778, GL-1-B04-20190486)
- Natural Science Foundation of Hunan Province (82273789, 82173691, 2022JJ30778, GL-1-B04-20190486)
- Chinese Pharmaceutical Association Biomedical Innovation Fund Project of Yiling (82273789, 82173691, 2022JJ30778, GL-1-B04-20190486)
This publication has 27 references indexed in Scilit:
- CDC20 overexpression predicts a poor prognosis for patients with colorectal cancerJournal of Translational Medicine, 2013
- Structural analysis of human Cdc20 supports multisite degron recognition by APC/CProceedings of the National Academy of Sciences, 2012
- Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progressionJournal of Hematology & Oncology, 2012
- SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C ActivityCancer Cell, 2011
- Structures of APC/CCdh1 with substrates identify Cdh1 and Apc10 as the D-box co-receptorNature, 2010
- Phosphorylation of Mcl‐1 by CDK1–cyclin B1 initiates its Cdc20‐dependent destruction during mitotic arrestThe EMBO Journal, 2010
- The spindle-assembly checkpoint in space and timeNature Reviews Molecular Cell Biology, 2007
- Cyclin-B1-mediated inhibition of excess separase is required for timely chromosome disjunctionJournal of Cell Science, 2006
- Dose‐dependent effects of stable cyclin B1 on progression through mitosis in human cellsThe EMBO Journal, 2006
- The WD40 Propeller Domain of Cdh1 Functions as a Destruction Box Receptor for APC/C SubstratesMolecular Cell, 2005